4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001258693-26-000013
CHIEF EXECUTIVE OFFICER sold 24,237 shares at an average $55.22 ($1,338,270)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-26 | Sale 10b5-1 | −6,683 | $54.28 | $362,720 | 468,020 | D: show line 1 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-26 | Sale 10b5-1 | −9,137 | $55.27 | $504,956 | 458,883 | D: show line 2 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-26 | Sale 10b5-1 | −6,417 | $56.12 | $360,128 | 452,466 | D: show line 3 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-26 | Sale 10b5-1 | −312 | $54.35 | $16,956 | 134,903 | I: show line 4 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-26 | Sale 10b5-1 | −356 | $55.23 | $19,660 | 134,547 | I: show line 5 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-26 | Sale 10b5-1 | −332 | $55.99 | $18,590 | 134,215 | I: show line 6 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-26 | Sale 10b5-1 | −207 | $54.22 | $11,224 | 135,008 | I: show line 7 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-26 | Sale 10b5-1 | −602 | $55.30 | $33,289 | 134,406 | I: show line 8 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2026-06-26 | Sale 10b5-1 | −191 | $56.27 | $10,747 | 134,215 | I: show line 9 in the form |
| Open-market sales · 24,237 sh · avg $55.22 · $1,338,270 | |||||||
Loading xslF345X06/wk-form4_1782514151.xml…